Spleen tyrosine kinase (Syk) inhibition in the treatment of autoimmune, allergic and autoinflammatory diseases. Preclinical studies presented compelling evidence that Syk inhibition may have therapeutic value in the treatment of rheumatoid arthritis and other forms of arthritis, systemic lupus erythematosus, autoimmune cytopenias, and allergic and autoinflammatory diseases. Pamuk ON Arthritis Res Ther. 2010 Dec 17;12(6):222. (UnboundMedline) (Also see: Autoimmunity)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
ISN Assistant News Guide
International Scleroderma Network(ISN)
Spleen tyrosine kinase (Syk) inhibition in the treatment of autoimmune, allergic and autoinflammatory diseases
No replies to this topic